- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01529814
Assessment of Integration Success of an Implant System With a Novel Abutment Attachment Design in Early Loaded Cases (Comet)
March 24, 2022 updated by: ZimVie
A Prospective Randomized-controlled Study of the Integration Success Rate of an Implant System With a Novel Abutment Attachment in Cases Loaded Early
Integration success rates measured by resistance to countertorque testing will be higher for the experimental implant design than for the control implants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by countertorque testing and cumulative success rate in cases that are loaded early
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Santiago, Chile
- Universidad Mayor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients of either sex and older than 18 years of age
- patients needing at least one dental implant to treat partial edentulism
- patients physically able to tolerate surgical and restorative dental procedures
- patients agreeing to all protocol visits
Exclusion Criteria:
- patients with infection or severe inflammation at the intended treatment sites
- patients smoking greater than 10 cigarettes per day
- patients with uncontrolled diabetes mellitus
- patients with uncontrolled metabolic diseases
- patients who received radiation treatment to the head in the past 12 months
- patients needing bone grafting at the intended treatment sites
- patients known to be pregnant at screening visit
- patients with para-functional habits like bruxing and clenching
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: New abutment connection implant
Implant with new abutment connection
|
New abutment connection implant system
Other Names:
|
Active Comparator: Nanotite Certain Tapered implant
Nanotite Certain Tapered (standard abutment connection) implant
|
Nanotite Certain Tapered (standard abutment connection) implant
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary stability countertorque measures
Time Frame: 2 months
|
Resistance to countertorque measures showing primary stability success of implants
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cumulative success rate
Time Frame: 2 years
|
Crestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carlos Montoya, DDS, Universidad Mayor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
February 7, 2012
First Submitted That Met QC Criteria
February 8, 2012
First Posted (Estimate)
February 9, 2012
Study Record Updates
Last Update Posted (Actual)
March 28, 2022
Last Update Submitted That Met QC Criteria
March 24, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Semmelweis UniversityInstitut Straumann AG; Geistlich Pharma AG; Dicomlab Kft.Recruiting
-
Fundación Eduardo AnituaActive, not recruitingPartial-edentulismSpain
-
Fundación Eduardo AnituaActive, not recruitingPartial-edentulismSpain
-
University of Colorado, DenverCompletedPartial EdentulismUnited States
-
University of BaghdadUnknown
-
Navigate Surgical Technologies Inc.CompletedPartial EdentulismCanada
-
Institut Straumann AGCompletedPartial EdentulismUnited States, Austria, Germany, Ireland, Netherlands, Portugal, Spain, Sweden, Switzerland
-
Institut Straumann AGCompletedPartial Edentulism
Clinical Trials on Nanotite Certain Tapered implant
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseBelgium, France, Germany, United Kingdom
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseColombia
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieActive, not recruiting
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseUnited States
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseSpain
-
Dentsply Sirona ImplantsCompletedJaw, Edentulous, PartiallyUnited States, Canada
-
Institut Straumann AGActive, not recruiting